View Item 

Show simple item record

Diabetes and prediabetes in patients with hepatitis B residing in North America
dc.contributor.authorKhalili, Mandanaen_US
dc.contributor.authorLombardero, Manuelen_US
dc.contributor.authorChung, Raymond T.en_US
dc.contributor.authorTerrault, Norah A.en_US
dc.contributor.authorGhany, Marc G.en_US
dc.contributor.authorKim, W. Rayen_US
dc.contributor.authorLau, Darylen_US
dc.contributor.authorLisker‐melman, Mauricioen_US
dc.contributor.authorSanyal, Arunen_US
dc.contributor.authorLok, Anna S.en_US
dc.contributor.authorRoberts, Lewis R.en_US
dc.date.accessioned2015-11-12T21:04:27Z
dc.date.available2017-01-03T16:21:17Zen
dc.date.issued2015-11en_US
dc.identifier.citationKhalili, Mandana; Lombardero, Manuel; Chung, Raymond T.; Terrault, Norah A.; Ghany, Marc G.; Kim, W. Ray; Lau, Daryl; Lisker‐melman, Mauricio ; Sanyal, Arun; Lok, Anna S.; Roberts, Lewis R. (2015). "Diabetes and prediabetes in patients with hepatitis B residing in North America." Hepatology 62(5): 1364-1374.en_US
dc.identifier.issn0270-9139en_US
dc.identifier.issn1527-3350en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/115977
dc.publisherWiley Periodicals, Inc.en_US
dc.titleDiabetes and prediabetes in patients with hepatitis B residing in North Americaen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/115977/1/hep28110-sup-0001-suppinfo01.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/115977/2/hep28110.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/115977/3/hep28110_am.pdf
dc.identifier.doi10.1002/hep.28110en_US
dc.identifier.sourceHepatologyen_US
dc.identifier.citedreferenceNational Institute of Alcohol and Alcoholism. Available at: http://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking. Accessed January 15, 2015.en_US
dc.identifier.citedreferenceImazeki F, Yokosuka O, Fukai K, Kanda T, Kojima H, Saisho H. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus‐infected and hepatitis C virus‐cleared patients. Liver Int 2008; 28: 355 ‐ 362.en_US
dc.identifier.citedreferencePapatheodoridis GV, Chrysanthos N, Savvas S, Sevastianos V, Kafiri G, Petraki K, Manesis EK. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis. J Viral Hepat 2006; 13: 303 ‐ 310.en_US
dc.identifier.citedreferenceIroezindu MO, Isiguzo GC, Young EE. Prevalence and predictors of impaired fasting glucose among Nigerian patients with hepatitis B virus infection. Diabetes Res Clin Pract 2012; 98: 338 ‐ 345.en_US
dc.identifier.citedreferenceSpradling PR, Simons B, Narayanan M, Xing J, Homan C, Bulkow L, et al. Incidence of diabetes mellitus in a population‐based cohort of persons with chronic hepatitis B virus infection. J Viral Hepat 2013; 20: 510 ‐ 513.en_US
dc.identifier.citedreferenceGhany M, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, et al. Characteristics of adults in the Hepatitis B Research Network in North America reflect their country of origin and HBV genotype. Clin Gastroenterol Hepatol 2015; 13: 183 ‐ 192.en_US
dc.identifier.citedreferenceStandards of medical care in diabetes—2015. Diabetes Care 2015; 38 ( Suppl 1 ): S5 ‐ S87.en_US
dc.identifier.citedreferenceDiagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37 ( Suppl 1 ): S81 ‐ 90.en_US
dc.identifier.citedreferenceAppropriate body‐mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157 ‐ 163.en_US
dc.identifier.citedreferenceAlberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640 ‐ 1645.en_US
dc.identifier.citedreferenceWai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518 ‐ 526.en_US
dc.identifier.citedreferenceChow W. A look at various estimators in logistic models in the presence of missing values. In: Proceedings of Business and Economics Section, American Statistical Association. Washington, DC: The Rand Corporation; 1979:417‐420.en_US
dc.identifier.citedreferenceWhiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94: 311 ‐ 321.en_US
dc.identifier.citedreferenceYisahak SF, Beagley J, Hambleton IR, Narayan KM. Diabetes in North America and the Caribbean: an update. Diabetes Res Clin Pract 2014; 103: 223 ‐ 230.en_US
dc.identifier.citedreferenceVanni E, Abate ML, Gentilcore E, Hickman I, Gambino R, Cassader M, et al. Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C. Hepatology 2009; 50: 697 ‐ 706.en_US
dc.identifier.citedreferenceBurman BE, Bacchetti P, Ayala CE, Gelman N, Melgar J, Khalili M. Liver inflammation is a risk factor for prediabetes in at‐risk latinos with and without hepatitis C infection. Liver Int 2015; 35: 101 ‐ 107.en_US
dc.identifier.citedreferenceBolukbas C, Bolukbas FF, Horoz M, Aslan M, Celik H, Erel O. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis 2005; 5: 95.en_US
dc.identifier.citedreferenceChen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65 ‐ 73.en_US
dc.identifier.citedreferenceIloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006; 130: 678 ‐ 686.en_US
dc.identifier.citedreferenceCorlin L, Woodin M, Thanikachalam M, Lowe L, Brugge D. Evidence for the healthy immigrant effect in older Chinese immigrants: a cross‐sectional study. BMC Public Health 2014; 14: 603.en_US
dc.identifier.citedreferenceKoya DL, Egede LE. Association between length of residence and cardiovascular disease risk factors among an ethnically diverse group of United States immigrants. J Gen Intern Med 2007; 22: 841 ‐ 846.en_US
dc.identifier.citedreferenceAfable‐Munsuz A, Mayeda ER, Perez‐Stable EJ, Haan MN. Immigrant generation and diabetes risk among Mexican Americans: the Sacramento Area Latino Study on Aging. Am J Public Health 2013; 103: e45 ‐ e52.en_US
dc.identifier.citedreferenceBullard KM, Saydah SH, Imperatore G, Cowie CC, Gregg EW, Geiss LS, et al. Secular changes in U.S. Prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999‐2010. Diabetes Care 2013; 36: 2286 ‐ 2293.en_US
dc.identifier.citedreferenceDaniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis—United States, 2007. MMWR Surveill Summ 2009; 58: 1 ‐ 27.en_US
dc.identifier.citedreferenceLok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661 ‐ 662.en_US
dc.identifier.citedreferenceKowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign‐born persons living in the United States by country of origin. Hepatology 2012; 56: 422 ‐ 433.en_US
dc.identifier.citedreferenceMcMahon BJ. Chronic hepatitis B virus infection. Med Clin North Am 2014; 98: 39 ‐ 54.en_US
dc.identifier.citedreferenceYounossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9: 524 ‐ 530.e1; quiz, e560.en_US
dc.identifier.citedreferenceWong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009; 58: 111 ‐ 117.en_US
dc.identifier.citedreferenceWang YY, Lin SY, Sheu WH, Liu PH, Tung KC. Obesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infection. Metabolism 2010; 59: 486 ‐ 491.en_US
dc.identifier.citedreferenceLee IC, Huang YH, Chan CC, Huo TI, Chu CJ, Lai CR, et al. Impact of body mass index and viral load on liver histology in hepatitis B e antigen‐negative chronic hepatitis B. Clin Nutr 2011; 30: 647 ‐ 652.en_US
dc.identifier.citedreferenceWong GL, Chan HL, Yu Z, Chan AW, Choi PC, Chim AM, et al. Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B—a prospective cohort study with paired transient elastography examinations. Aliment Pharmacol Ther 2014; 39: 883 ‐ 893.en_US
dc.identifier.citedreferenceYoon H, Lee JG, Yoo JH, Son MS, Kim DY, Hwang SG, Rim KS. Effects of metabolic syndrome on fibrosis in chronic viral hepatitis. Gut Liver 2013; 7: 469 ‐ 474.en_US
dc.identifier.citedreferenceStepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population‐based study. Gut 2010; 59: 1410 ‐ 1415.en_US
dc.identifier.citedreferenceUse of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2011; 60: 1709 ‐ 1711.en_US
dc.identifier.citedreferenceChen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow‐up study in Taiwan. Gastroenterology 2008; 135: 111 ‐ 121.en_US
dc.identifier.citedreferenceNathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30: 753 ‐ 759.en_US
dc.identifier.citedreferenceNational Diabetes Statistic Report. 2014. Available at: http://www.cdc.gov/diabetes/pdfs/data/2014-report-estimates-of-diabetes-and-its-burden-in-the-united-states.pdf. Accessed May 1, 2015.en_US
dc.identifier.citedreferenceArao M, Murase K, Kusakabe A, Yoshioka K, Fukuzawa Y, Ishikawa T, et al. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J Gastroenterol 2003; 38: 355 ‐ 360.en_US
dc.identifier.citedreferenceCotler SJ, Dhamija MK, Luc BJ, Siqueira F, Bartram AH, Layden TJ, Wong SS. The prevalence and clinical correlates of elevated ALT levels in an urban Chinatown community. J Viral Hepat 2010; 17: 148 ‐ 152.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hep28110-sup-0001-suppinfo01.pdf
Size:
59.05KB
Format:
PDF
View/Open
Name:
hep28110.pdf
Size:
584.6KB
Format:
PDF
View/Open
Name:
hep28110_am.pdf
Size:
636.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.